A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Renal Allograft Tolerance Through Mixed Chimerism
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Thalidomide, Lenalidomide, and Rituximab for Previously Treated Waldenstrom Macroglobulinemia
- Status
- TERMINATED
- Phase
- PHASE2
A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis
- Status
- TERMINATED
- Phase
- PHASE3
Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy
- Status
- TERMINATED
- Phase
- PHASE3
Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL
- Status
- COMPLETED
- Phase
- PHASE2
A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab in Systemic Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
- Status
- TERMINATED
- Phase
- PHASE3
Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a
- Status
- COMPLETED
- Phase
- PHASE3